Table of Content

1 Long-acting and Short-acting Oral Contraceptives Market Overview
1.1 Product Overview and Scope of Long-acting and Short-acting Oral Contraceptives
1.2 Long-acting and Short-acting Oral Contraceptives Segment by Type
1.2.1 Global Long-acting and Short-acting Oral Contraceptives Market Value Comparison by Type (2024-2034)
1.2.2 Combined Contraceptive Pill
1.2.3 Low Dose Oral Contraceptive
1.3 Long-acting and Short-acting Oral Contraceptives Segment by Application
1.3.1 Global Long-acting and Short-acting Oral Contraceptives Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Global Long-acting and Short-acting Oral Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Long-acting and Short-acting Oral Contraceptives Revenue 2018-2029
1.4.2 Global Long-acting and Short-acting Oral Contraceptives Sales 2018-2029
1.4.3 Global Long-acting and Short-acting Oral Contraceptives Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Long-acting and Short-acting Oral Contraceptives Market Competition by Manufacturers
2.1 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Manufacturers (2018-2024)
2.2 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturers (2018-2024)
2.4 Global Long-acting and Short-acting Oral Contraceptives Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Product Type & Application
2.7 Long-acting and Short-acting Oral Contraceptives Market Competitive Situation and Trends
2.7.1 Long-acting and Short-acting Oral Contraceptives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Long-acting and Short-acting Oral Contraceptives Players Market Share by Revenue
2.7.3 Global Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Long-acting and Short-acting Oral Contraceptives Retrospective Market Scenario by Region
3.1 Global Long-acting and Short-acting Oral Contraceptives Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Long-acting and Short-acting Oral Contraceptives Global Long-acting and Short-acting Oral Contraceptives Sales by Region: 2018-2029
3.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Region: 2018-2024
3.2.2 Global Long-acting and Short-acting Oral Contraceptives Sales by Region: 2024-2029
3.3 Global Long-acting and Short-acting Oral Contraceptives Global Long-acting and Short-acting Oral Contraceptives Revenue by Region: 2018-2029
3.3.1 Global Long-acting and Short-acting Oral Contraceptives Revenue by Region: 2018-2024
3.3.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Region: 2024-2029
3.4 North America Long-acting and Short-acting Oral Contraceptives Market Facts & Figures by Country
3.4.1 North America Long-acting and Short-acting Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
3.4.3 North America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting and Short-acting Oral Contraceptives Market Facts & Figures by Country
3.5.1 Europe Long-acting and Short-acting Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
3.5.3 Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting and Short-acting Oral Contraceptives Market Facts & Figures by Country
3.6.1 Asia Pacific Long-acting and Short-acting Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
3.6.3 Asia Pacific Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting and Short-acting Oral Contraceptives Market Facts & Figures by Country
3.7.1 Latin America Long-acting and Short-acting Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
3.7.3 Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2029)
4.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024)
4.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029)
4.1.3 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2029)
4.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2029)
4.2.1 Global Long-acting and Short-acting Oral Contraceptives Revenue by Type (2018-2024)
4.2.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Type (2024-2029)
4.2.3 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2029)
4.3 Global Long-acting and Short-acting Oral Contraceptives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2029)
5.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024)
5.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029)
5.1.3 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2029)
5.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2029)
5.2.1 Global Long-acting and Short-acting Oral Contraceptives Revenue by Application (2018-2024)
5.2.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Application (2024-2029)
5.2.3 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2029)
5.3 Global Long-acting and Short-acting Oral Contraceptives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bayer Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Paladin Labs
6.2.1 Paladin Labs Corporation Information
6.2.2 Paladin Labs Description and Business Overview
6.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.2.5 Paladin Labs Recent Developments/Updates
6.3 Theramex (Teva)
6.3.1 Theramex (Teva) Corporation Information
6.3.2 Theramex (Teva) Description and Business Overview
6.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.3.5 Theramex (Teva) Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Corporation Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Apotex Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 HRA Pharma
6.6.1 HRA Pharma Corporation Information
6.6.2 HRA Pharma Description and Business Overview
6.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.6.4 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.6.5 HRA Pharma Recent Developments/Updates
6.7 HLL Life Care
6.6.1 HLL Life Care Corporation Information
6.6.2 HLL Life Care Description and Business Overview
6.6.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.4.4 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.7.5 HLL Life Care Recent Developments/Updates
6.8 Mankind
6.8.1 Mankind Corporation Information
6.8.2 Mankind Description and Business Overview
6.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Mankind Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.8.5 Mankind Recent Developments/Updates
6.9 Piramal
6.9.1 Piramal Corporation Information
6.9.2 Piramal Description and Business Overview
6.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Piramal Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.9.5 Piramal Recent Developments/Updates
6.10 Allergan
6.10.1 Allergan Corporation Information
6.10.2 Allergan Description and Business Overview
6.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Allergan Long-acting and Short-acting Oral Contraceptives Product Portfolio
6.10.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting and Short-acting Oral Contraceptives Industry Chain Analysis
7.2 Long-acting and Short-acting Oral Contraceptives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting and Short-acting Oral Contraceptives Production Mode & Process
7.4 Long-acting and Short-acting Oral Contraceptives Sales and Marketing
7.4.1 Long-acting and Short-acting Oral Contraceptives Sales Channels
7.4.2 Long-acting and Short-acting Oral Contraceptives Distributors
7.5 Long-acting and Short-acting Oral Contraceptives Customers
8 Long-acting and Short-acting Oral Contraceptives Market Dynamics
8.1 Long-acting and Short-acting Oral Contraceptives Industry Trends
8.2 Long-acting and Short-acting Oral Contraceptives Market Drivers
8.3 Long-acting and Short-acting Oral Contraceptives Market Challenges
8.4 Long-acting and Short-acting Oral Contraceptives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Long-acting and Short-acting Oral Contraceptives Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Long-acting and Short-acting Oral Contraceptives Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Long-acting and Short-acting Oral Contraceptives Market Competitive Situation by Manufacturers in 2022
Table 4. Global Long-acting and Short-acting Oral Contraceptives Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Long-acting and Short-acting Oral Contraceptives Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Long-acting and Short-acting Oral Contraceptives Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Long-acting and Short-acting Oral Contraceptives, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Product Type & Application
Table 12. Global Key Manufacturers of Long-acting and Short-acting Oral Contraceptives, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting and Short-acting Oral Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting and Short-acting Oral Contraceptives as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting and Short-acting Oral Contraceptives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (K Units)
Table 18. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2018-2024)
Table 19. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 20. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2024-2029)
Table 21. Global Long-acting and Short-acting Oral Contraceptives Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2018-2024)
Table 23. Global Long-acting and Short-acting Oral Contraceptives Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2024-2029)
Table 25. North America Long-acting and Short-acting Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 27. North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 28. North America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 32. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 33. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Long-acting and Short-acting Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Long-acting and Short-acting Oral Contraceptives Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Long-acting and Short-acting Oral Contraceptives Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Long-acting and Short-acting Oral Contraceptives Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Long-acting and Short-acting Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Type (2018-2024)
Table 51. Global Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Type (2024-2029)
Table 52. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2018-2024)
Table 53. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2024-2029)
Table 54. Global Long-acting and Short-acting Oral Contraceptives Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Long-acting and Short-acting Oral Contraceptives Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2018-2024)
Table 57. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Type (2024-2029)
Table 58. Global Long-acting and Short-acting Oral Contraceptives Price (US$/Unit) by Type (2018-2024)
Table 59. Global Long-acting and Short-acting Oral Contraceptives Price (US$/Unit) by Type (2024-2029)
Table 60. Global Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Application (2018-2024)
Table 61. Global Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Application (2024-2029)
Table 62. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2018-2024)
Table 63. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application (2024-2029)
Table 64. Global Long-acting and Short-acting Oral Contraceptives Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Long-acting and Short-acting Oral Contraceptives Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2018-2024)
Table 67. Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Application (2024-2029)
Table 68. Global Long-acting and Short-acting Oral Contraceptives Price (US$/Unit) by Application (2018-2024)
Table 69. Global Long-acting and Short-acting Oral Contraceptives Price (US$/Unit) by Application (2024-2029)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Bayer Long-acting and Short-acting Oral Contraceptives Product
Table 74. Bayer Recent Developments/Updates
Table 75. Paladin Labs Corporation Information
Table 76. Paladin Labs Description and Business Overview
Table 77. Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Paladin Labs Long-acting and Short-acting Oral Contraceptives Product
Table 79. Paladin Labs Recent Developments/Updates
Table 80. Theramex (Teva) Corporation Information
Table 81. Theramex (Teva) Description and Business Overview
Table 82. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product
Table 84. Theramex (Teva) Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Pfizer Long-acting and Short-acting Oral Contraceptives Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Apotex Corporation Information
Table 91. Apotex Description and Business Overview
Table 92. Apotex Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Apotex Long-acting and Short-acting Oral Contraceptives Product
Table 94. Apotex Recent Developments/Updates
Table 95. HRA Pharma Corporation Information
Table 96. HRA Pharma Description and Business Overview
Table 97. HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. HRA Pharma Long-acting and Short-acting Oral Contraceptives Product
Table 99. HRA Pharma Recent Developments/Updates
Table 100. HLL Life Care Corporation Information
Table 101. HLL Life Care Description and Business Overview
Table 102. HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. HLL Life Care Long-acting and Short-acting Oral Contraceptives Product
Table 104. HLL Life Care Recent Developments/Updates
Table 105. Mankind Corporation Information
Table 106. Mankind Description and Business Overview
Table 107. Mankind Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Mankind Long-acting and Short-acting Oral Contraceptives Product
Table 109. Mankind Recent Developments/Updates
Table 110. Piramal Corporation Information
Table 111. Piramal Description and Business Overview
Table 112. Piramal Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Piramal Long-acting and Short-acting Oral Contraceptives Product
Table 114. Piramal Recent Developments/Updates
Table 115. Allergan Corporation Information
Table 116. Allergan Description and Business Overview
Table 117. Allergan Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Allergan Long-acting and Short-acting Oral Contraceptives Product
Table 119. Allergan Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Long-acting and Short-acting Oral Contraceptives Distributors List
Table 123. Long-acting and Short-acting Oral Contraceptives Customers List
Table 124. Long-acting and Short-acting Oral Contraceptives Market Trends
Table 125. Long-acting and Short-acting Oral Contraceptives Market Drivers
Table 126. Long-acting and Short-acting Oral Contraceptives Market Challenges
Table 127. Long-acting and Short-acting Oral Contraceptives Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Long-acting and Short-acting Oral Contraceptives
Figure 2. Global Long-acting and Short-acting Oral Contraceptives Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Long-acting and Short-acting Oral Contraceptives Market Share by Type in 2022 & 2029
Figure 4. Combined Contraceptive Pill Product Picture
Figure 5. Low Dose Oral Contraceptive Product Picture
Figure 6. Global Long-acting and Short-acting Oral Contraceptives Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Long-acting and Short-acting Oral Contraceptives Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacies
Figure 9. Private Clinics
Figure 10. Retail Pharmacies
Figure 11. E-Commerce
Figure 12. Global Long-acting and Short-acting Oral Contraceptives Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Long-acting and Short-acting Oral Contraceptives Market Size (2018-2029) & (US$ Million)
Figure 14. Global Long-acting and Short-acting Oral Contraceptives Sales (2018-2029) & (K Units)
Figure 15. Global Long-acting and Short-acting Oral Contraceptives Average Price (US$/Unit) & (2018-2029)
Figure 16. Long-acting and Short-acting Oral Contraceptives Report Years Considered
Figure 17. Long-acting and Short-acting Oral Contraceptives Sales Share by Manufacturers in 2022
Figure 18. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Long-acting and Short-acting Oral Contraceptives Players: Market Share by Revenue in 2022
Figure 20. Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Long-acting and Short-acting Oral Contraceptives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 23. North America Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 24. United States Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 27. Europe Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 28. Germany Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Region (2018-2029)
Figure 35. China Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 43. Latin America Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Long-acting and Short-acting Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Long-acting and Short-acting Oral Contraceptives by Type (2018-2029)
Figure 53. Global Revenue Market Share of Long-acting and Short-acting Oral Contraceptives by Type (2018-2029)
Figure 54. Global Long-acting and Short-acting Oral Contraceptives Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Long-acting and Short-acting Oral Contraceptives by Application (2018-2029)
Figure 56. Global Revenue Market Share of Long-acting and Short-acting Oral Contraceptives by Application (2018-2029)
Figure 57. Global Long-acting and Short-acting Oral Contraceptives Price (US$/Unit) by Application (2018-2029)
Figure 58. Long-acting and Short-acting Oral Contraceptives Value Chain
Figure 59. Long-acting and Short-acting Oral Contraceptives Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed